Wouter A. van der Zwan

1.6k total citations · 1 hit paper
12 papers, 1.2k citations indexed

About

Wouter A. van der Zwan is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Wouter A. van der Zwan has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Oncology and 5 papers in Neurology. Recurrent topics in Wouter A. van der Zwan's work include Neuroendocrine Tumor Research Advances (10 papers), Lung Cancer Research Studies (9 papers) and Neuroblastoma Research and Treatments (5 papers). Wouter A. van der Zwan is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), Lung Cancer Research Studies (9 papers) and Neuroblastoma Research and Treatments (5 papers). Wouter A. van der Zwan collaborates with scholars based in Netherlands, United States and Italy. Wouter A. van der Zwan's co-authors include Dik J. Kwekkeboom, Eric P. Krenning, Wouter W. de Herder, Boen L.R. Kam, Jaap J.M. Teunissen, Richard A. Feelders, Tessa Brabander, Casper H.J. van Eijck, Gaston J H Franssen and Lisa Bodei and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Clinical Cancer Research.

In The Last Decade

Wouter A. van der Zwan

12 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

2017 416 citations Tessa Brabander, Wouter A. van der Zwan et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wouter A. van der Zwan Netherlands	9	851	784	650	207	154	12	1.2k
Chiara Grana Italy	7	283 0.3×	318 0.4×	206 0.3×	281 1.4×	34 0.2×	8	696
Ali Chahlavi United States	14	194 0.2×	257 0.3×	177 0.3×	67 0.3×	22 0.1×	21	872
C. Özcelik Germany	16	265 0.3×	292 0.4×	35 0.1×	97 0.5×	64 0.4×	27	1.4k
Mélanie Pagès France	16	217 0.3×	83 0.1×	399 0.6×	183 0.9×	13 0.1×	31	1.1k
Sara J. Felten United States	10	157 0.2×	149 0.2×	142 0.2×	170 0.8×	16 0.1×	15	991
R.C. McGarry United States	14	51 0.1×	197 0.3×	83 0.1×	197 1.0×	79 0.5×	43	908
Jun-ichi Adachi Japan	18	129 0.2×	149 0.2×	169 0.3×	22 0.1×	19 0.1×	57	715
Roberto Tonelli Italy	19	52 0.1×	230 0.3×	287 0.4×	38 0.2×	37 0.2×	42	1.1k
Garth Cruickshank United Kingdom	15	46 0.1×	179 0.2×	106 0.2×	166 0.8×	55 0.4×	23	899
Nicolai El Hindy Germany	18	104 0.1×	56 0.1×	243 0.4×	134 0.6×	9 0.1×	42	792

Countries citing papers authored by Wouter A. van der Zwan

Since Specialization

Citations

This map shows the geographic impact of Wouter A. van der Zwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter A. van der Zwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter A. van der Zwan more than expected).

Fields of papers citing papers by Wouter A. van der Zwan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter A. van der Zwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter A. van der Zwan. The network helps show where Wouter A. van der Zwan may publish in the future.

Co-authorship network of co-authors of Wouter A. van der Zwan

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter A. van der Zwan. A scholar is included among the top collaborators of Wouter A. van der Zwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter A. van der Zwan. Wouter A. van der Zwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bodei, Lisa, Aviral Singh, Wouter A. van der Zwan, et al.. (2020). PRRT neuroendocrine tumor response assessment using blood transcript analysis: The NETest.. Journal of Clinical Oncology. 38(4_suppl). 625–625. 1 indexed citations

Bodei, Lisa, Mark Kidd, Aviral Singh, et al.. (2019). PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest. European Journal of Nuclear Medicine and Molecular Imaging. 47(4). 895–906. 79 indexed citations

Zwan, Wouter A. van der, Tessa Brabander, Boen L.R. Kam, et al.. (2018). Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 46(3). 704–717. 99 indexed citations

Bodei, Lisa, Mark Kidd, Aviral Singh, et al.. (2018). PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy. European Journal of Nuclear Medicine and Molecular Imaging. 45(7). 1155–1169. 96 indexed citations

Bodei, Lisa, Mark Kidd, Aviral Singh, et al.. (2018). Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of ¹⁷⁷lu-octreotate efficacy.. Journal of Clinical Oncology. 36(15_suppl). 4101–4101. 1 indexed citations

Brabander, Tessa, Wouter A. van der Zwan, Jaap J.M. Teunissen, et al.. (2017). Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors. Clinical Cancer Research. 23(16). 4617–4624. 416 indexed citations breakdown →

Brabander, Tessa, Wouter A. van der Zwan, Jaap J.M. Teunissen, et al.. (2017). Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate. Endocrine Related Cancer. 24(5). 243–251. 47 indexed citations

Bodei, Lisa, Mark Kidd, Wouter A. van der Zwan, et al.. (2017). Blood measurements of neuroendocrine tumor (NET) transcripts and gene cluster analysis to predict efficacy of peptide radioreceptor therapy.. Journal of Clinical Oncology. 35(15_suppl). 4091–4091. 2 indexed citations

Bergsma, Hendrik, Mark Konijnenberg, Wouter A. van der Zwan, et al.. (2016). Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate. European Journal of Nuclear Medicine and Molecular Imaging. 43(10). 1802–1811. 128 indexed citations

10.

Zwan, Wouter A. van der, Lisa Bodei, Jan Mueller‐Brand, et al.. (2014). GEP–NETs UPDATE: Radionuclide therapy in neuroendocrine tumors. European Journal of Endocrinology. 172(1). R1–R8. 97 indexed citations

11.

Kapitein, Lukas C., Kah Wai Yau, Susana Montenegro Gouveia, et al.. (2011). NMDA Receptor Activation Suppresses Microtubule Growth and Spine Entry. Journal of Neuroscience. 31(22). 8194–8209. 97 indexed citations

12.

Kapitein, Lukas C., Max A. Schlager, Wouter A. van der Zwan, et al.. (2010). Probing Intracellular Motor Protein Activity Using an Inducible Cargo Trafficking Assay. Biophysical Journal. 99(7). 2143–2152. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact